News

<< First  < Prev   1   2   Next >  Last >> 
  • 2015-09-04 15:48 | Russell Read (Administrator)

    The American Uveitis Society announces that its Fall Meeting will be held in conjunction with the AAO Annual Meeting in Las Vegas, NV on October 15, 2015 at Treasure Island.  Members and guests are invited to join the AUS for a social hour from 7 to 8 PM with the scientific meeting to follow immediately at 8 PM.

    AUS members who's dues are current may attend the meeting at no charge. A guest fee of $50 is accessed for others, but is  waived for non-AUS members who are the presenter of a free paper.

    Dr. Emmett Cunningham will moderate “Controversies in Uveitis.  Case-based comments from a non-consensus panel of experts", followed by a free paper session. The program committee invites abstracts presenting research that will not be presented at the AAO meeting.  Case presentations will be considered if they are of sufficient interest.  Please only submit one abstract per first author.  

    Abstract submission will be electronic and the submission site is now open. Submissions will close on September 30, 2015. Decisions will be made by October 9, 2015 and the corresponding author notified via email.  

    Sincerely,

    Nisha Acharya, M.D., M.S.

    nisha.acharya@ucsf.edu

    Program Chair, AUS Fall Meeting


    Russell W. Read, MD, PhD

    rwread@gmail.com

    Executive Secretary

    American Uveitis Society

     

  • 2015-06-15 20:28 | Russell Read (Administrator)
    The American Uveitis Society joined the Alliance for Eye and Vision Research (AEVR) and other societies and patient advocacy groups to co-sponsor the first ever Congressional Briefing on Uveitis. AUS member Gary N. Holland, MD, Professor of Ophthalmology at the David Geffen School of Medicine at UCLA and Jack H. Skirball Chair in Ocular Inflammatory Diseases, was a featured speaker.

    Left to right: Gary N Holland MD (Jules Stein Eye Institute, David Geffen School of Medicine at UCLA), Janine Austin Clayton MD (National Institutes of Health Associate Director for Research on Women’s Health), and James Jorkasky ( Executive Director of AEVR/NAEVR).

     Full details of the briefing can be found on the AEVR website.
  • 2015-05-09 07:43 | Russell Read (Administrator)

    The 13th Congress of the International Ocular Inflammation Society will be held in San Francisco from September 25 to 27, 2015. This will be the first IOIS Congress to be held in the US. More than 25 societies focused on ocular inflammation will host sessions during the three day meeting along with IOIS Sections focused on all aspects of ocular immunology and disease. Further details can be found at the Congress website.

  • 2015-03-22 15:44 | Russell Read (Administrator)

    The National Eye Institute (NEI and US Food and Drug Administration (FDA) are holding a public Workshop on Endpoints for Ocular Inflammatory Diseases on the campus of the NIH on March 26, 2015 in the Masur Auditorium.

    Details regarding the meeting can be found here:

    2015 NEI/FDA Endpoints Workshop


  • 2015-02-03 12:00 | Russell Read (Administrator)

    The MUST Research Group, which successfully completed the Multicenter Uveitis Steroid Treatment (MUST) Trial is conducting two new trials, the Periocular and Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial and the Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy (MERIT) Trial. Both are funded by the National Eye Institute. POINT will compare the relative efficacy of three common approaches for the regional treatment of uveitic macular edema, periocular and intravitreal triamcinolone acetonide, and the dexamethasone intravitreal implant. MERIT will evaluate the relative efficacy of intravitreal ranibizumab and intravitreal methotrexate and the dexamethasone intravitreal implant for the treatment of uveitic macular edema persisting after intravitreal triamcinolone acetonide. The POINT Trial will be initiated in Spring 2015 in clinical centers that are currently following participants in the MUST Trial Follow-up Study and to have new clinical centers selected and preparing for start-up by the time of our Research Group meeting in June 2015. The MERIT Trial will begin approximately 12 months after the start of POINT; the trials will run concurrently until POINT is completed.

    Those interested in being a clinical center for POINT and MERIT should visit the Clinic Applications site or read the attached document to learn more.

  • 2015-01-21 15:56 | Russell Read (Administrator)

    Abstract submission for FOCIS 2015 closes Wednesday, January 15. 

    The American Uveitis Society is a member society of FOCIS, the Federation of Clinical Immunology Societies.

  • 2015-01-20 17:46 | Russell Read (Administrator)

    Interesting application for the iPhone that allows you to help a low vision person with a specific issue via a video/audio link on your iPhone.

    Be My Eyes - iTunes App Store Link

  • 2015-01-16 10:40 | Russell Read (Administrator)

    The American Uveitis Society is proud to reveal its most extensive update to UveitisSociety.org since its inception. This complete revamping will result in enhanced membership customer service by allowing members to view and update their profile information, track their membership status and pay dues online, and provides an enhanced Uveitis Specialist Directory through which patients can easily access clinician contact information.

<< First  < Prev   1   2   Next >  Last >> 

Copyright © The American Uveitis Society
All rights reserved

700 18th Street South Suite 601
Birmingham Alabama 35233 USA

The American Uveitis Society is a 501(c)6 non-profit organization

Powered by Wild Apricot Membership Software